Show Summary Details

Page of

PRINTED FROM OXFORD HANDBOOKS ONLINE (www.oxfordhandbooks.com). © Oxford University Press, 2018. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Handbooks Online for personal use (for details see Privacy Policy and Legal Notice).

date: 11 December 2019

Abstract and Keywords

This chapter examines how obsessive-compulsive disorder (OCD) may be effectively treated using biologic approaches. Early recognition and intervention with combined cognitive behavioral and medication therapy limit its subsequent morbidity. Selective serotonin reuptake inhibitors (SSRIs) and clomipramine are central in acute and maintenance pharmacotherapy of OCD, often requiring high dosage. Augmenting agents include low-dose typical and atypical antipsychotic agents, among others. As OCD appears to be a chronic waxing and waning illness, effective medications should be continued for at least 1 to 2 years. Relapse rates tend to be high following medication discontinuation, although a history of cognitive behavioral therapy limits this risk. In severe treatment-refractory cases, surgical and somatic therapies such as deep brain stimulation have been used.

Keywords: deep brain stimulation, medication, obsessive-compulsive disorder, pharmacology, somatic, surgery, treatment

Access to the complete content on Oxford Handbooks Online requires a subscription or purchase. Public users are able to search the site and view the abstracts and keywords for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can''t find the answer there, please contact us.